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No single randomized study has ever before addressed the safety of On-Pump coronary
artery bypass grafting (CABG) vs Off-Pump CABG in the setting of atrial fibrillation (AF) and
data from small observational samples remain inconclusive.
Methods and findings
Procedural data from KROK (Polish National Registry of Cardiac Surgery Procedures) were
retrospectively collected. Of initial 188,972 patients undergoing CABG, 7,913 presented
with baseline AF (76.0% men, mean age 69.1±8.2) and underwent CABG without concomi-
tant valve surgery between 2006–2019 in 37 reference centers across Poland. Mean follow-
up was 4.7±3.5 years (median 4.3 IQR 1.7–7.4). Cox proportional hazards models were
used for computations. Of included patients, 3,681 underwent On-Pump- (46.52%) as
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compared to 4,232 (53.48%) who underwent Off-Pump CABG. Patients in the latter group
less frequently were candidates for complete revascularization (P<0.001). In an unadjusted
comparison, On-Pump surgery was associated with significantly worse survival at 30 days:
HR: 1.28; 95%CIs: (1.07–1.53); P = 0.007. Along the 13-year study period, the trend shifted
in favor of On-Pump CABG: HR: 0.92; 95%CIs: (0.83–0.99); P = 0.005. After rigorous pro-
pensity matching, 636 pairs were identified. The direction and magnitude of treatment
effects was sustained with HRs of 3.58; (95%CIs: 1.34–9.61); p = 0.001 and 0.74; [95%CIs:
0.56–0.98]; p = 0.036) for 30-day and late mortality respectively.
Conclusions
Off-Pump CABG offered 30-day survival benefit to patients undergoing CABG surgery and
presenting with underlying AF. On-Pump CABG was associated with significantly improved
survival at long term.
Introduction
Although the presence of atrial fibrillation (AF) in patients undergoing coronary artery bypass
grafting (CABG) is much less than their mitral valve surgery counterparts, still approximately
6% of patients presenting for coronary surgical procedures have preoperative AF [1–3] that
often plays as a marker for high-risk patients’ populations [4]. This percentage is known to fur-
ther increase with older age, and depressed left ventricular function [5] that is in patients more
and more frequently referred for CABG surgery. There exists robust evidence to support per-
forming CABG in higher risk patients [6,7] without the use of cardiopulmonary bypass (CPB)
(Off-Pump CABG) to avoid deleterious effects of extracorporeal circulation (ECC) and its con-
sequences: transfusions, renal failure, bleeding and cerebrovascular events [8]. On the other
hand, On-Pump CABG and arrested heart offer bloodless operative field and allow complete
revascularization in most, often very complex cases [9–11].
No single randomized study has ever before addressed the safety of On-Pump CABG vs
Off-Pump CABG in this particular setting of AF and data from small observational samples
remains inconclusive [12,13]. Driven by this fact, we designed an analysis, in which we report
long-term survival results after On-Pump and Off-Pump CABG in AF from the Polish




The current work represents an anonymous registry analysis; the long-term data are provided
by the Polish NHS; IRB approval was lifted. All data were collective in a retrospective fashion
from the KROK registry (available at: www.krok.csioz.gov.pl). The registry is an ongoing,
nationwide, multi-institutional registry of heart surgery procedures in Poland [14]. The regis-
try is an initiative of the Society of Polish Cardiac Surgeons in cooperation with the Polish
Ministry of Health that commenced in 2006 and collects data from all 37 heart surgery centers
in Poland (List of contributing centers—Appendix). Centers enrolling patients in the KROK
registry are required to transfer the data concerning every cardiac surgery to the central data-
base in the National Centre for Healthcare Information Systems at the Ministry of Health and
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cardiopulmonary bypass; ECC, extracorporeal
circulation; MV, mitral valve; STS, Society of
Thoracic Surgeons; KROK, ‘Krajowy Rejestr
Operacji Kardiochirurgicznych’ (Polish National
Registry of Cardiac Surgery Procedures); LVEF, left
ventricle ejection fraction; CAD, coronary artery
disease; MI, myocardial infarction; PCI,
percutaneous coronary intervention; IABP, intra-
aortic balloon pump; ICU, intensive care unit;
HLoS, hospital length of stay; HR, hazard ratio; CI,
confidence interval; SMD, standardized mean
difference.
are financially liable for data integrity and completeness. Follow-up data regarding mortality
were obtained from the National Health Fund—the nationwide, obligatory, public health
insurance institution in Poland and incorporated to the registry. A registry module for collect-
ing the data regarding myocardial infarctions (MI), hospitalizations due to unstable angina,
subsequent revascularizations, strokes and other complications was under construction at the
time of analysis.
Data collection
A detailed questionnaire, defined according to standard definitions, including demographic
data, history, physical findings, management, imaging studies, and outcomes, was developed.
Data were collected either at presentation or by physician review of the hospital records and
were forwarded to the KROK registry. The forms were reviewed for clinical face- and analyti-
cal internal -validity.
Study population and clinical variables
Using the KROK participant user file, we identified adult patients undergoing CABG surgery
between 2006–2019. Excluded were those without history of AF or AF at time of presentation
and CABG procedures combined with valve(s) surgery. No further exclusion criteria were
imposed with regard to patients’ baseline status. For patients undergoing CABG surgery, we
considered and report 3 categories of variables as potentially influencing the primary endpoint:
1) baseline demographics: age, gender, EuroSCORE [15], diabetes, body mass, hypertension,
poor mobility, pulmonary hypertension, chronic kidney disease, vascular disease, chronic lung
disease and LVEF; 2) extent of CAD: previous MI, previous PCI (percutaneous coronary inter-
vention), left main (LM) disease; and 3) surgical characteristics: redo-surgery, endocarditis,
cardiogenic shock, intra-aortic balloon pump (IABP), critical preoperative state, iv. inotropes/
nitrates, aortic no-touch, total arterial revascularization [TAR]) and completeness of
revascularization.
Primary endpoint assessed was late survival in On-Pump vs Off-Pump CABG. Analyses of
early postoperative mortality (<24 hours) and 30-day mortality were performed as well. In-
hospital complications as well as length of intensive care unit (ICU) and hospital stay (HLoS)
are reported.
Statistical analysis
Missing data were handled with artificial neural networks using Long Short-Term Memory
hidden units [16, 17] only to the threshold of up to 5% of missing data [18]. Continuous, nor-
mally distributed variables were summarized as mean±standard deviation; variables with non-
normal distributions were summarized as median (interquartile range; IQR) and compared
with the Mann–Whitney U test or standard t test as appropriate. Categorical variables were
expressed as number (%) and compared with the Fisher exact test. Cox proportional-hazards
models were used to determine factors related the event-free survival. The ensuing statistical
models were used to define the Hazard Ratios (HRs) point estimate and 95% confidence inter-
vals (95% CI) of the effect size and to evaluate the differences with respect to mode of CABG
surgery. Respective HRs for the comparison On-Pump vs Off-Pump CABG were calculated
and reported first for the univariable Cox proportional-hazards model taking into account all
sets of variables categorized by: 1) baseline demographics; 2) extent of CAD; and 3) surgical
characteristics. Next, a multivariable model was built, again stratified on the 3 sets of variables.
Interaction between univariable and multivariable was assessed with the use of the Cochran–
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Mantel–Haenszel test after data were stratified. Multivariable model was then tested for
multicollinearity.
Propensity score analysis was performed to balance possible confounding between the two
study groups with regard to selected variables in order to prevent any bias related to the initial
selection of patients for CABG surgery. Propensity scores were computed using a multiple
logistic regression model, in which the dependent variable was concomitant ablation and the
independent variables were the ones for which the given variable returned an estimated effect
of�0.1 change in respective HR after multiple logistic regression. Regression adjustment was
then fitted resulting in increased precision for continuous outcome as described by Steyerberg
[19]. In the final model, we tested the zero variance using the model proposed by Drikwandi
et al. [20] to obtain good operating characteristics with respect to type I error and power. A
greedy match using nearest-neighbor method was used and 1-to-1 ratio, without replacement,
within a specific caliper width of 0.2 SD of the LOGIT of the estimated propensity score. Pro-
pensity scores along with Wald (χ2) are reported with corresponding 95%CIs. To verify the
balance between On-Pump vs Off-Pump CABG groups after PS-matching, the standardized
mean differences (SMDs) were computed. For the selected PS-matched population univariable
and multivariable Cox proportional hazard models were tested again and statistical differences
reported. Overall late and 30-day mortality was assessed with Kaplan Meier curves fitted before
(unadjusted model) and after PS-matching. As a sensitivity analysis to assess the survival after
On-Pump vs Off-Pump CABG, patients were stratified according to defined subgroups and
respective models unadjusted and PS-matched redone. STATA MP v13.0 software (StataCorp,
College Station, TX) was used for computations.
Results
During 13-year study period 188,972 patients undergoing CABG surgery were identified.
Among those, 7,913 initially presented with AF and did not undergo concomitant valvular sur-
gery. Subjects were divided into On-Pump- (3,681 [46.52%]) and Off-Pump CABG (4,232
[53.48%]). Fig 1. Mean follow-up was 4.7±3.5 years (median 4.3 IQR 1.7–7.4).
Baseline characteristics
Baseline characteristics along with clinical and surgical data are listed in Table 1. There were
no marked differences between On-Pump and Off-Pump CABG with respect to age and distri-
bution of patients across baseline LVEF percentages. Subjects undergoing Off-Pump CABG
were more often female (p<0.001) and diabetic (p<0.001) yet lower risk (eg. EuroSCORE <2:
71% vs 65%; p<0.001) as compared to On-Pump CABG. On-Pump CABG group included
more three-vessel disease patients (p<0.001) that however less frequently had history of MI
(p<0.001)
Regarding clinical characteristics at time of procedure, significantly more cases of cardio-
genic shock (p = 0.022), critical preoperative state (p<0.001) and insertion of IABP preopera-
tively (p = 0.003) were included in On-Pump CABG subset of patients. Majority of included
patients were of elective- status (4,842 [61.2%]) followed by urgent- (2,858 [36.1%]) and emer-
gency- (190 [2.4%]) with similar distribution across On-Pump and Off-Pump groups. The
details on operative data is further available in Table 2.
Operative and long-term data
Average CPB time was estimated at 84.1±42.6 minutes, while X-clamp was 46.2±46.3 minutes.
Concomitant AF ablation was performed significantly more often in On-Pump CABG group
as compared to Off-Pump CABG (209 [5.7%] vs 137 [3.2%]; P<0.001). Left internal mammary
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artery (LIMA) grafts were used in 79.3% of cases and more frequently in Off-Pump CABG (81.2%
vs 77.0%, p<0.001); pedicled IMA was harvested almost twice as often as skeletonized IMA
(61.1% vs 35.4%). Complete revascularization was possible in 67.5% of patients and was signifi-
cantly higher, by 10%, in patients undergoing On-Pump CABG (73.3% vs 62.6%; P<0.001).
While arterial anastomoses accounted for 38.5% of all distal anastomoses, total arterial revasculari-
zation was achieved in 19.6% of overall population with over three-fold higher rates in Off-Pump
CABG (p<0.001). Aortic no-touch technique was used in 34.5% of Off-Pump cases. Conversions
from Off-Pump to On-Pump followed in 81 patients accounting for 1.9%.
Median (IQR) HLoS was 10 (8–14) days and ICU stay was 1.17 (0.91–1.50). The HLoS was
significantly longer in On-Pump CABG as compared to Off-Pump (std. mean diff. [95%CIs]
0.166 [0.121, 0.210] day or 3.98 [2.90–5.04] hours, p<0.001) and so was length of ICU stay
(std. mean diff. [95%CIs] 0.212 [0.168, 0.257] day or 5.09 [4.03–6.17] hours, p<0.001).
In unadjusted analysis, On-Pump CABG was associated with increased rates of postopera-
tive complications, among them cardiac tamponade and/or rethoracotomy for bleeding,
Fig 1. Flow diagram of the current study cohort undergoing On-Pump and Off-Pump CABG surgery in concomitant atrial fibrillation. AF, atrial
fibrillation; CABG, coronary artery bypass grafting; PS, propensity score.
https://doi.org/10.1371/journal.pone.0231950.g001
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Table 1. Preoperative characteristics before and after PS-matching.
Variable All patients PS-matched patients










age years (median [IQR]) 70 [63–75] 70 [63–75] 70 [64–75] 0.476 68 [61–74] 68 [61–73] 68 [61–74] 0.788
<50 121 (1.53%) 49 (1.33%) 72 (1.70%) 0.181 19 (1.49%) 10 (1.57%) 9 (1.42%) 0.879
50–70 3,751
(47.40%)
1,761 (47.84%) 1,990 (47.02%) 0.468 697 (54.79%) 349 (54.87%) 348 (54.72%) 0.913
>70 4,041
(51.07%)




2,883 (78.32%) 3,133 (74.03%) <0.001 1,019
(80.11%)
508 (79.87%) 511 (80.35%) 0.833
female 1,897
(23.97%)
798 (21.68%) 1,099 (25.97%) 253 (19.89%) 128 (20.13%) 125 (19.65%)
EuroSCORE (median [IQR]) 1.35 [0.89–
2.43]
1.49 [0.98–2.69] 1.22 [0.82–2.23] <0.001 0.97 (0.74–
1.33)
0.97 [0.74–1.32] 0.96 [0.75–1.34] 0.874
<2 5,378
(67.96%)
2,375 (64.52%) 3,003 (70.96%) <0.001 1,114
(87.58%)
558 (987.73%) 556 (87.42%) 0.865
2–5 1,780
(22.49%)
888 (24.12%) 892 (21.08%) 0.001 152 (11.95%) 75 (11.79%) 77 (12.10%) 0.895
>5 755 (9.54%) 418 (11.36%) 337 (7.96%) <0.001 6 (0.47%) 3 (0.47%) 3 (0.47%) 0.999
diabetes 3,262
(41.22%)
1,455 (39.53%) 1,807 (42.70%) 0.004 483 (37.97%) 241 (37.89%) 242 (38.05%) 0.954
diet only 489 (6.18%) 160 (4.35%) 329 (7.77%) <0.001 52 (4.09%) 26 (4.09%) 26 (4.09%) 0.999
oral hypoglycemic drugs 1,401
(17.71%)
712 (19.34%) 689 (16.28%) <0.001 241 (18.94%) 127 (19.97%) 114 (17.425) 0.352




586 (15.92%) 788 (18.62%) 0.002 185 (14.54%) 86 (13.52%) 99 (15.57%) 0.301
smoking 4,787
(60.50%)
2,074 (56.34%) 2,713 (64.11%) <0.001 161 (12.66%) 75 (11.79%) 86 (13.52%) 0.354
hypertension 7,136
(90.18%)
3,331 (90.49%) 3,805 (89.91%) 0.368 1,138
(89.47%)
570 (89.62%) 568 (89.31%) 0.855
hyperlipidemia 5,024
(63.49%)
2,229 (60.55%) 2,795 (66.04%) <0.001 803 (63.12%) 398 (62.58%) 405 (63.68%) 0.684
poor mobility 401 (5.07%) 224 (6.09%) 177 (4.18%) <0.001 25 (1.97%) 11 (1.73%) 14 (2.20%) 0.544
BMI (median [IQR]) 28.4 [25.7–
31.5]
28.5 [25.8–31.6] 28.4 [25.6–31.5] 0.273 28.6 [26.1–
31.4]
28.6 [26.2–31.5] 28.7 [26.0–31.6] 0.377
pulmonary hypertension 394 (4.98%) 132 (3.59%) 262 (6.19%) <0.001 2 (0.16%) 0 (0.0%) 2 (0.31%) 0.156
moderate (PA systolic 31–55
mmHg)
346 (4.37%) 113 (3.07%) 233 (5.51%) <0.001 2 (0.16%) 0 (0.00%) 2 (0.31%) 0.156
severe (PA systolic >55
mmHg)
48 (0.61%) 19 (0.52%) 29 (0.69%) 0.335 0 (0.0%) 0 (0.00%) 0 (0.00%) N/A
renal impairment 2,404
(30.38%)
1,248 (33.90%) 1,156 (27.32%) <0.001 228 (17.92%) 110 (17.29%) 118 (18.55%) 0.559
moderate (CC >50 & <85) 1,860
(23.51%)
964 (26.19%) 896 (21.17%) <0.001 203 (15.96%) 96 (15.09%) 107 (16.82%) 0.399
severe (CC <50) 503 (6.36%) 263 (7.14%) 240 (5.67%) 0.007 21 (1.65%) 13 (2.04%) 8 (1.26%) 0.268
dialysis (regardless of CC) 43 (0.54%) 21 (0.57%) 22 (0.52%) 0.760 4 (0.31%) 1 (0.16%) 3 (0.47%) 0.316
peripheral artery disease 1,519
(19.20%)
596 (16.19%) 923 (21.81%) <0.001 142 (11.16%) 66 (10.38%) 76 (11.95%) 0.373
cerebrovascular disease 753 (9.52%) 349 (9.48%) 404 (9.55%) 0.921 77 (6.05%) 31 (4.87%) 46 (7.23%) 0.077
history of stroke 304 (3.84%) 145 (3.94%) 159 (3.76%) 0.674 40 (3.14%) 21 (3.30%) 19 (2.99%) 0.748
(Continued)
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Table 1. (Continued)
Variable All patients PS-matched patients









history of TIA 305 (3.85%) 173 (4.70%) 132 (3.12%) <0.001 16 (1.26%) 8 (1.26%) 8 (1.26%) 0.999
carotid intervention 113 (1.43%) 54 (1.47%) 59 (1.39%) 0.785 6 (0.47%) 4 (0.63%) 2 (0.31%) 0.413
chronic lung disease 694 (8.77%) 279 (7.58%) 415 (9.81%) <0.001 49 (3.85%) 30 (4.72%) 19 (2.99%) 0.109
asthma 295 (3.73%) 144 (3.91%) 151 (3.57%) 0.421 7 (0.55%) 5 (0.79%) 2 (0.31%) 0.255
LVEF (%) (median [IQR])� 50 [40–55] 50 [40–55] 50 [40–55] 0.031 50 [43–59] 50 [45–60] 50 [42–59] 0.456
<20% 120 (1.75%) 65 (1.94%) 55 (1.57%) 0.254 4 (0.31%) 2 (0.31%) 2 (0.31%) 0.999
21–30% 627 (9.15%) 306 (9.12%) 321 (9.19%) 0.918 8 (0.63%) 4 (0.63%) 4 (0.63%) 0.999
31–50% 3,578
(52.24%)
1,765 (52.59%) 1,813 (51.90%) 0.568 620 (48.74%) 310 (48.74%) 310 (48.74%) 0.999
>50% 2,524
(36.85%)
1,220 (36.35%) 1,304 (37.33%) 0.401 640 (50.31%) 320 (50.31%) 320 (50.31%) 0.999
CAD�
1 VD 692 (9.13%) 225 (6.30%) 467 (11.66%) <0.001 103 (8.10%) 46 (7.23%) 57 (8.96%) 0.259
2 VD 2,383
(31.45%)
1,000 (27.99%) 1,383 (34.54%) <0.001 426 (33.49%) 203 (31.92%) 223 (35.06%) 0.235
3 VD 4,502
(59.42%)
2,348 (65.72%) 2,154 (53.80%) <0.001 743 (58.41%) 387 (60.85%) 356 (55.97%) 0.078
LM disease 2,217
(29.26%)
1,034 (28.94%) 1,183 (29.55%) 0.563 324 (26.51%) 162 (26.51%) 162 (26.51%) 0.999
previous MI 4,363
(55.14%)
1,958 (53.19%) 2,405 (56.83%) 0.001 606 (47.64%) 301 (47.33%) 305 (47.95%) 0.822
>1 871 (11.01%) 389 (10.57%) 482 (11.39%) 0.244 72 (5.66%) 36 (5.66%) 36 (5.66%) 0.999
previous PCI 1,875
(23.70%)




528 (14.34%) 533 (12.59%) 0.023 273 (21.46%) 136 (21.38%) 137 (21.82%) 0.822
I 1,655
(20.91%)
789 (21.43%) 866 (20.46%) 0.289 284 (22.33%) 142 (22.33%) 142 (22.33%) 0.999
II 3,690
(46.63%)
1,690 (45.91%) 2,000 (47.26%) 0.231 592 (46.54%) 295 (46.38%) 297 (46.69%) 0.994
III 1,238
(15.65%)
534 (14.51%) 704 (16.64%) 0.009 116 (9.12%) 60 (9.46%) 56 (8.80%) 0.697
IV 269 (3.40%) 140 (3.80%) 129 (3.05%) 0.065 7 (0.55%) 3 (0.47%) 4 (0.63%) 0.706
CCS
0 112 (1.42%) 61 (1.66%) 51 (1.21%) 0.090 526 (41.35%) 263 (41.35%) 263 (41.35%) 0.999
1 593 (7.49%) 362 (9.83%) 231 (5.46%) 0.000 104 (8.18%) 52 (8.18%) 52 (8.18%) 0.999
2 2,837
(35.85%)
1,326 (36.02%) 1,511 (35.70%) 0.768 284 (22.33%) 142 (22.33%) 142 (22.33%) 0.999
3 3,218
(40.67%)
1,397 (37.95%) 1,821 (43.03%) <0.001 286 (22.48%) 143 (22.48%) 143 (22.48%) 0.999
4 903 (11.41%) 419 (11.38%) 484 (11.44%) 0.940 72 (5.66%) 36 (5.66%) 36 (5.66%) 0.999
ACS 250 (3.16%) 116 (3.15%) 134 (3.17%) 0.970 10 (0.79%) 5 (0.79%) 5 (0.79%) 0.999
�missing data
CABG, coronary artery bypass grafting; PS, propensity score; IQR, interquartile range; BMI, body mass index; PA, pulmonary artery; CC, creatinine clearance; TIA,
transient ischemic attack; LVEF, left ventricle ejection fraction; CAD, coronary artery disease; VD, vessel disease; MI, myocardial infarction; PCI, percutaneous
coronary intervention; NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society.
https://doi.org/10.1371/journal.pone.0231950.t001
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Table 2. Operative characteristics before and after PS-matching.
Variable All patients PS-matched patients










Redo surgery 84 (1.06%) 37 (1.01%) 47 (1.11%) 0.648 0 (0.00%) 0 (0.00%) 0 (0.00%) 0.999
Cardiogenic chock 137 (1.73%) 77 (2.09%) 60 (1.42%) 0.022 3 (0.2350 1 (0.16%) 2 (0.31%) 0.563
Critical preoperative state 198 (2.50%) 129 (3.50%) 69 (1.63%) <0.001 0 (0.00%) 0 (0.00%) 0 (0.00%) 0.999
IABP 148 (1.87%) 87 (2.36%) 61 (1.44%) 0.003 28 (2.20%) 16 (2.52%) 12 (1.89%) 0.444
iv. inotropes 226 (2.86%) 117 (3.18%) 109 (2.58%) 0.109 9 (0.71%) 3 (0.47%) 6 (0.94%) 0.315
iv. nitrates 1,264
(15.97%)




2,241 (60.88%) 2,601 (61.46%) 0.597 918 (72.17%) 474 (74.53%) 444 (69.81%) 0.060
Urgent 2,858
(36.12%)
1,320 (35.86%) 1,538 (36.34%) 0.656 348 (27.36%) 159 (25.00%) 189 (29.72%) 0.059
Emergency 190 (2.40%) 101 (2.74%) 89 (2.10%) 0.064 1 (0.08%) 0 (0.00%) 1 (0.16%) 0.238
Salvage 27 (0.34%) 19 (0.52%) 8 (0.19%) 0.014 1 (0.08%) 0 (0.00%) 1 (0.16%) 0.238
Surgery
CPB [min]� - 84.1±42.6 NA NA - 79.3±32.1 NA NA
X-clamp [min]� - 46.2±46.3 NA NA - 48.4±48.9 NA NA
Aortic no-touch� 1,459
(18.44%)
NA 1,459 (34.48%) NA 0 (0.00%) NA 0 (0.00%) NA
Conversion 83 (1.05%) 2 (0.05%) 81 (1.91%) <0.001 0 (0.00%) 0 (0.00%) 0 (0.00%) 0.999
Concomitant ablation 346 (4.37%) 209 (5.68%) 137 (3.24%) <0.001 67 (5.27%) 35 (5.50%) 32 (5.03%) 0.706
Concomitant LAAO 70 (0.88%) 56 (1.52%) 14 (0.33%) <0.001 0 (0.00%) 0 (0.00%) 0 (0.00%) 0.999
Concomitant VSD repair 19 (0.24%) 19 (0.52%) NA NA NA NA
Concomitant ventricular
aneurysm repair




2,835 (77.02%) 3,436 (81.19%) <0.001 1,052
(82.70%)
529 (83.18%) 523 (82.26%) 0.656
RIMA 245 (3.10%) 86 (2.34%) 159 (3.76%) <0.001 6 (0.47%) 3 (0.47%) 3 (0.47%) 0.999
BIMA 223 (2.82%) 81 (2.20%) 142 (3.36%) 0.002 6 (0.47%) 3 (0.47%) 3 (0.47%) 0.999
Pedicled IMA 3,984
(61.14%)
1,876 (50.96%) 2,108 (49.81%) 0.306 1,268
(99.69%)
633 (99.53%) 635 (99.84%) 0.316
Skeletonized IMA 2,308
(35.42%)
961 (26.11%) 1,347 (31.83%) <0.001 364 (28.62%) 188 (29.56%) 176 (27.67%) 0.456
Radial artery 180 (2.27%) 72 (1.96%) 108 (2.55%) 0.076 3 (0.2350 1 (0.16%) 2 (0.31%) 0.563
Arterial anastomoses 7,940
(38.54%)
3,670 (35.19%) 4,270 (41.99%) <0.001 444 (34.91%) 221 (34.75%) 223 (35.06%) 0.906
Venous anastomoses 11,004
(53.42%)
6,076 (58.26%) 4,928 (48.46%) <0.001 615 (49.35%) 310 (48.74%) 305 (47.95%) 0.779
Sequential anastomoses 1,656 (8.04%) 684 (6.56%) 972 (9.56%) <0.001 21 (1.65%) 11 (1.73%) 10 (1.57%) 0.826





344 (9.35%) 1,211 (28.62%) <0.001 207 (16.27%) 103 (16.19%) 104 (16.35%) 0.939
�missing data
CABG, coronary artery bypass grafting; PS, propensity score; IABP, intra-aortic balloon pump; iv, intravenous; OPCAB, Off-Pump Coronary Artery Bypass; CPB,
cardiopulmonary bypass; LAAO, left atrial appendage occlusion; VSD, ventricular septal defect; LIMA/RIMA/BIMA, Left/Right/Bilateral Internal Mammary Artery;
NA, not available.
https://doi.org/10.1371/journal.pone.0231950.t002
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periprocedural MI, respiratory and multiorgan failure, gastrointestinal complications and
acute kidney injury. Early postoperative mortality was significantly higher in On-Pump
CABG: HR 1.74; 95%CI (1.09–2.78); p = 0.019. At 30-days On-Pump CABG was associated
with significant nearly 30% increased mortality risk: HR 1.28; 95%CI (1.07–1.53); p = 0.007.
Fig 2A. Within investigated follow-up unadjusted HR for long term survival, however, favored
On-Pump CABG: HR 0.92; 95%CI (0.83–0.99); p = 0.005 (Fig 2B and S1 File). List of remain-
ing in-hospital outcomes is available as Table 3.
Propensity score analysis
One-to-one propensity score–matched analysis resulted in 636 pairs with similar baseline
characteristics and operative covariates (Tables 1 and 2). List of variables contributing to PS
along with respective propensity scores is available as S1 Table. Detailed analysis of standard-
ized mean differences (SMDs) before and after propensity score matching comparing covari-
ate values for patients undergoing On-Pump vs Off-Pump CABG (S1 Fig) revealed that SMDs
for the measured covariates were mostly <0.1, suggesting covariate balance across groups. PS-
matched 30-day mortality was increased with On-Pump CABG and estimated to HR: 3.58;
(95%CIs: 1.34–9.61); p = 0.001. Fig 3A. Late mortality, on the other hand, was reduced in
patients undergoing On-Pump CABG (HR: 0.74; [95%CIs: 0.56–0.98]; p = 0.036). Fig 3B. Hos-
pital outcomes adjusted for PS are reported in Table 3. Among them a trend towards more fre-
quent incidence of cardiac tamponade and/or rethoracotomy was observed in On-Pump
CABG (HR: 1.51; [95%CIs: 0.96–2.39]; p = 0.073).
Sensitivity and subgroup analyses
Number of subgroup analyses were performed for comparison On-Pump vs Off-Pump before
and after PS-matching (Figs 4 and 5) with respect to the primary endpoint late survival. In
these analyses only two significant interactions with baseline (Fig 4) or procedural (Fig 5) vari-
ables were demonstrated; indeed, the benefit of On-Pump CABG was more gradually less pro-
nounced with growing CCS scale (P = 0.008), (Fig 4); operatively, there was higher extent of
survival benefit in Off-Pump CABG when both sequential and/or composite anastomoses
Fig 2. Unadjusted Kaplan-Meier survival curves between the two groups: On-Pump and Off-Pump CABG for the analysis of 30-day (A) and late (B) survival. Hazard
Ratios and respective 95% Confidence Intervals in the On-Pump as compared to Off-Pump CABG.
https://doi.org/10.1371/journal.pone.0231950.g002
PLOS ONE On-Pump vs off-pump CABG in AF
PLOS ONE | https://doi.org/10.1371/journal.pone.0231950 April 22, 2020 9 / 20
were performed (P = 0.014 and P = 0.072 respectively); On-Pump CABG was beneficial in case
these were not used (P = 0.009 and P = 0.051), (Fig 5). After PS-matching, the direction of ben-
efit with On-Pump CABG was maintained across subgroups of patients as compared to
Table 3. In-hospital outcomes before and after PS-matching.














Early postoperative mortality 44 (1.20%) 29 (0.69%) 1.74 (1.09–2.78) 0.019 8 (1.25%) 1 (0.16%) 8.00 (1.01–63.78) 0.049
30-day mortality 238 (6.47%) 214 (5.06%) 1.28 (1.07–1.53) 0.007 18 (2.83%) 5 (0.79%) 3.58 (1.34–9.61) 0.001
Cardiac tamponade and/or
rethoracotomy
226 (6.14%) 177 (4.18%) 1.47 (1.21–1.78) <0.001 44 (6.92%) 29 (4.56%) 1.51 (0.96–2.39) 0.073
Periprocedural MI 53 (1.44%) 37 (0.87%) 1.65 (1.08–2.50) 0.019 2 (0.31%) 2 (0.31%) 1.00 (0.14–7.07) 0.999
Respiratory failure 255 (6.93%) 243 (5.74%) 1.21 (1.02–1.43) 0.031 31 (4.87%) 25 (3.93%) 1.24 (0.74–2.07) 0.413
Prolonged ICU stay 50 (1.36%) 64 (1.51%) 0.90 (0.62–1.30) 0.567 3 (0.47%) 9 (1.42%) 0.33 (0.91–1.22) 0.098
Neurologic complications 93 (2.53%) 90 (2.13%) 1.19 (0.89–1.58) 0.238 2 (0.31%) 2 (0.31%) 1.00 (0.14–7.07) 0.999
Multiorgan failure 99 (2.69%) 79 (1.87%) 1.44 (1.08–1.93) 0.014 6 (0.94%) 8 (1.26%) 0.75 (0.26–2.15) 0.592
Gastrointestinal complications 69 (1.87%) 50 (1.18%) 1.59 (1.11–2.28) 0.012 4 (0.63%) 7 (1.10%) 0.57 (0.16–1.54) 0.370
Acute kidney failure and/or
dialysis
146 (3.97%) 95 (2.24%) 1.77 (1.37–2.28) <0.001 6 (0.94%) 8 (1.26%) 0.75 (0.26–2.15) 0.592
Superficial sternal wound
infection
65 (1.77%) 78 (1.84%) 0.96 (0.69–1.33) 0.797 7 (1.10%) 9 (1.42%) 0.77 (0.29–2.07) 0.616
Deep sternal wound infection 47 (1.28%) 48 (1.13%) 1.13 (0.75–1.68) 0.561 8 (1.26%) 4 (0.63%) 2.00 (0.61–6.61) 0.256
Mediastinitis 30 (0.81%) 24 (0.57%) 1.44 (0.84–2.45) 0.184 3 (0.47%) 2 (0.31%) 1.50 (0.25–8.94) 0.656
PPI 10 (0.27%) 9 (0.21%) 1.28 (0.52–3.14) 0.594 0 (0.00%) 0 (0.00%) 1.00 (0.02–50.32) 0.999
ECMO 11 (0.30%) 2 (0.05%) 6.32 (1.4–28.51) 0.016 1 (0.16%) 0 (0.00%) 3.00 (0.12–73.51) 0.501
IABP 193 (5.24%) 156 (3.69%) 1.42 (1.16–1.75) <0.001 16 (2.52%) 12 (1.89%) 1.33 (0.64–2.80) 0.446
CABG, coronary artery bypass grafting; PS, propensity score; CIs, confidence intervals; MI, myocardial infarction; ICU, intensive care unit; PPI, permanent pacemekar
implantation; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump.
https://doi.org/10.1371/journal.pone.0231950.t003
Fig 3. Propensity matched Kaplan-Meier survival curves between the two groups: On-Pump and Off-Pump CABG for the analysis of 30-day (A) and late (B) survival.
Hazard Ratios and respective 95% Confidence Intervals in the On-Pump as compared to Off-Pump CABG.
https://doi.org/10.1371/journal.pone.0231950.g003
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unadjusted estimates, yet was particularly present in patients with lower baseline surgical risk
such as those with EuroSCORE <2; preserved ejection fraction and without comorbidities.
The detailed analysis with reporting for both univariable and multivariable Cox proportional
hazards model is appended as S2 Table.
Discussion
With all limitations and selection bias inherent to registry analyses, that were however taken
account for by matching for propensity scores, the current report from one of Europe’s largest
registries on heart surgery procedures shows robust evidence to support as follows: in patients
with underlying AF and undergoing CABG 1) off-pump CABG was associated with improved
short-term survival; 2) over the study course there was a shift in survival favoring on-pump
CABG in the long-term; 3) performing sequential/composite anastomoses yielded survival
benefits during off-pump CABG.
Although the presence of AF in patients undergoing CABG is much less than their MV sur-
gery counterparts, still approximately 6% of patients presenting for coronary surgery have pre-
operative AF [1,3] regardless of the AF origin (eg. valvular vs non-valvular). Preoperative AF
was found to be associated with a higher adjusted 30-day mortality and morbidity including
stroke, renal failure, prolonged ventilation, reoperation, and deep sternal wound complica-
tions; patients with preoperative AF also experience a higher adjusted long-term risk of all-
cause mortality and cumulative risk of stroke and systemic embolism compared to those with-
out AF [21,22]. Said that, AF patients undergoing CABG, regardless of the initial EuroSCORE
may be considered high risk.
Concept of risk gradient in CABG, and in particular in comparison On-Pump CABG vs
Off-Pump has been well defined [8]. Yet controversies remain as while there have been studies
showing the potential benefits of OPCAB in this sub-group of patients, there is still a lot to be
learned from the patient selection and application of this technique. Previous observational
studies suggested that, by avoiding the negative effects of cardiopulmonary bypass, off-pump
CABG may substantially reduce mortality and morbidity rates when compared with conven-
tional on-pump CABG [6,23,24]. These benefits, however, have never been confirmed in a sin-
gle randomized controlled trial (RCT). Veterans Affairs Randomized On/Off Bypass
(ROOBY) trial [25] demonstrated no significant difference between off-pump and on-pump
CABG in the incidence of the 30-day composite endpoint of death, reoperation, new mechani-
cal support, cardiac arrest, coma, stroke, or renal failure (7.0% and 5.6%, respectively;
P = 0.19). Similarly, the largest trial to date, the CABG Off or On Pump Revascularization
Study (CORONARY) [26] which included more than 4700 patients randomized to OPCAB
and conventional CABG, showed no difference between these 2 approaches with regard to
30-day rate of mortality, myocardial infarction (MI), stroke, or renal failure requiring dialysis.
Indeed, the only RCT designed to address “elevated” risk patients exclusively was the German
Off-Pump Coronary Artery Bypass Grafting in Elderly Patients (GOPCABE) trial which also
found that in elderly patients�75 years, five-year survival rates as well as the combined out-
come of death, MI and repeat revascularization were similar after on-pump and off-pump
Fig 4. Hazard ratios and 95% confidence intervals for death from any cause in the On-Pump as compared to Off-Pump CABG
according to selected preoperative baseline characteristics. CABG, coronary artery bypass grafting; PA, pulmonary artery; CC,
creatinine clearance; TIA, transient ischemic attack; LVEF, left ventricle ejection fraction; CAD, coronary artery disease; VD, vessel
disease; LM, left main; MI, myocardial infarction; PCI, percutaneous coronary intervention; CCS, Canadian Cardiovascular Society;
ACS, acute coronary syndrome; NYHA, New York Heart Association; PS, propensity score; NA, not available. � P value for the
treatment effect. �� P value for the interaction between pre- and post PS-matching estimates. ��� P value for the interaction between
subgroup components (after PS-matching).
https://doi.org/10.1371/journal.pone.0231950.g004
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CABG [27]. It is the GOPCABE investigators who recently issued a post-hoc sub-analysis of
off-pump vs on-pump trial focusing on patients with preoperative AF [13]. With similar preva-
lence of AF across subgroups (10% on-pump, 10% off-pump), AF patients, as expected, had
worse preoperative conditions, which, in turn, had a negative impact on outcome; combined
end-point of death, MI, stroke, dialysis and revascularization occurred more often (13 vs 8%,
P = 0.008) and 30-day mortality was significantly higher (6 vs 2%, P = 0.003) in AF patients.
However, the operative technique used for CABG did not affect these outcome parameters.
Neutrality of these results must be viewed in light of low mortality and other complications’
rates in patients undergoing CABG nowadays and, in particular, in patients selected for enroll-
ment in a RCT. On the other hand, current analysis is placed in all-comers scenario and
allowed for inclusion of almost 8,000 AF patients undergoing CABG which is more than any
RCT (233 pts. In GOPCABE) or RCTs combined ever had.
First and most important finding of the current report is that as compared to Off-Pump,
On-Pump CABG was associated with higher early (24 hours) and 30-day all-cause mortality
after PS matching (HR [95%CIs]: 8.00 [1.01–63.78] P = 0.049; and 3.58 [1.34–9.61] P = 0.001
respectively). The finding is in line with another report from Attaran [12] that while not pow-
ered for hard clinical endpoints, demonstrated that patients undergoing on-pump CABG,
presence of underlying AF was associated with poorer postoperative outcomes; inotropic sup-
port rates as well as need for IABP support remained significantly higher in AF, even after
adjusting for preoperative characteristics. Authors suggested more apparent and negative
effect of CPB in patients with AF at short-term; even despite maintaining acceptable perfusion
pressures during CPB. Generalized hypoperfusion [28] together with deleterious effects of
CPB itself further increases rates of postoperative complications and early mortality. Before
adjusting for PS in the current analysis, patients undergoing On-Pump CABG experienced
more cardiac tamponades/reoperations for bleeding, periprocedural MIs, respiratory and mul-
tiorgan failures, acute kidney injuries and ECMO/IABP support; yet, these differences were no
longer prominent after matching.
Secondly, late mortality, on the other hand, was reduced in patients undergoing On-Pump
CABG (HR: 0.74; [95%CIs: 0.56–0.98]; p = 0.036). In the present analysis we were able to show
for the first time a shift in the survival which favored Off-Pump in the short term and then
On-Pump in the remote observations leading to conclusions that factors other than baseline
characteristics play a role in forging the late postoperative course. Completeness of revasculari-
zation has long been claimed to influence remote survival after CABG [10,11,29] and present
report is no exception. A completeness of revascularization index (CRI) was calculated based
on the difference between the number of coronary grafts and the number of diseased coronary
artery systems as reported in the KROK database; CR was more frequently achieved in the On-
Pump CABG group (73.3% vs 62.6%; P<0.001); again, this reflects findings of recent studies
confirming OPCAB being associated with less grafts per patient and less complete revasculari-
zation [29–31]. Since the above were found to be linked to increased incidence of recurrent
angina, need for repeat revascularization procedures (both PCI and re-CABG), and more fre-
quent rehospitalization for cardiac-related issues, particular over the course of mid-term fol-
low-up [9], achieving CR and in particular in high-risk patient is of paramount importance.
Experience factor, not accounted for in the current analysis, is not to be missed however, since
when multiple arterial grafts are used and a complete revascularization is performed in centres
Fig 5. Hazard ratios and 95% confidence intervals for death from any cause in the On-Pump as compared to Off-Pump CABG
according to selected procedural characteristics. IABP, intra-aortic balloon pump; iv, intravenous; LIMA/RIMA/BIMA, left/right/bilateral
internal mammary artery. LAAO, left atrial appendage occlusion; VAD, ventricle assist device. Remaining abbreviations as in Fig 4.
https://doi.org/10.1371/journal.pone.0231950.g005
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experienced in OPCAB or performing OPCABs only, reported outcomes are equivalent to
those of ONCAB procedures [32–34].
Third and unexpected finding of the current analysis is the significant interaction between
survival estimates in On-Pump vs Off-Pump CABG when composite and sequential anasto-
moses were performed. We were able to demonstrate that whenever these were not used dur-
ing On-Pump translated into improved survival; on the other hand, a non-significant yet ‘not
to be missed’ trend for improved survival with Off-Pump CABG was seen in cases composite
and sequential anastomoses were performed; it is hard to discuss on potential explanations for
this phenomenon in the absence of angiographic follow-up; yet it may be assumed that given
higher global number of venous anastomoses in the On-Pump (58.3% vs 48.5%) and arterial-
in the Off-Pump-CABG (41.2% vs 35.2%), the quality of sequential and/or composite venous
anastomosis is far inferior to one arterial- over time, leading to differences in survival estimates
between the two groups.
Interpreting the above, caution must be used however with regard to low reported rates of
surgical ablation since both early and late patency of the grafts seems to be greatly influenced
by postoperative rhythm; in the studies assessing blood flow through the grafts, AF caused sig-
nificant deterioration in hemodynamics: heart rate and central venous pressure increased, and
mean arterial pressure and cardiac index decreased (P = 0.003). In LIMA grafts, the flow
decreased significantly in AF (P<0.001) as measured using transit-time flowmetry [35,36]. By
avoiding postoperative AF, the vulnerable grafts are protected against diastolic impairment
and low cardiac output syndrome that is prominent in case of arrhythmias [37] and are less
likely to fail. Surgical ablation concomitant to CABG surgery was performed in 4.4% in the
overall population (5.7% On-Pump vs 3.2% Off-Pump CABG) and is much lower prevalence
than observed in Society of Thoracic Surgery reports (17%-30%) [1,3] which we find disturb-
ing. Yet, ablation procedures concomitant to CABG are not reimbursed neither in Poland nor
in majority of European countries [38]; therefore, surgical ablation at time of isolated CABG is
performed at physicians’ discretion or driven by industry funded research programs. Latest
report from the KROK registry has found that surgical ablation performed for AF at time of
isolated CABG was associated with significantly improved remote survival [39]; therefore,
addition of arrhythmias correction surgery could have further improved the survival rates
equally (P interaction = 0.228) in both On-Pump and Off-Pump CABG in the current analysis.
Current study purpose was not to end a “On-pump vs Off-pump never ending debate”,
rather it adds fuel to it pointing to certain limitations and advantages of one approach over the
other in the setting of AF. From the largest CABG and AF multicenter registry to-date, it
seems reasonable to individualize the treatment and tailor the CABG surgery to the AF patient,
having in mind that Off-Pump CABG confers short term survival benefits and should strongly
be considered in high risk patient. On the other hand, patients in the lower risk groups, with
otherwise longer life expectancy will survive to benefit from higher rates of complete revascu-
larization offered by On-Pump CABG.
Limitations
Limitations of the KROK registry have been described before [14]. Completeness of revascu-
larization rates are lower than what is observed in STS reports [1–3]. Contributing to lower
rates of CR in the Off-Pump CABG group is the fact that minimally invasive direct coronary
artery bypass (MIDCABs) were not excluded from the analysis. Hybrid procedures (MIDCAB:
LIMA-LAD followed by PCI to remaining lesions) is widely performed and in particular
recently. Index of complete revascularization, on the other hand, was calculated based on the
difference between the number of coronary grafts and not target lesions revascularization.
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Secondly, we could not account for left atrial appendage (LAA) closure rates; in the current
report these are certainly underscored; further, ablation- durations, techniques and -immedi-
ate success rates since these were not obligatory to complete during registry conception as well
and these data are incomplete. LIMA grafts were used in only 80% of patients, yet it must be
noted, the registry covers an almost 15-year time span and included both elective and emer-
gency CABG procedures together with ACS, dialysis and redo surgeries. Finally, since the reg-
istry is anonymous, we could not adjust for centers’ and surgeons’ volume and experience with
one technique or another.
Conclusions
Off-Pump CABG offered 30-day survival benefit to patients undergoing CABG surgery and
presenting with underlying AF. On-Pump CABG was associated with significantly improved
survival at long term.
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hypertension; IMA. internal mammary artery; LM. left main; ACS. acute coronary syndrome
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larization.
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